OCC 0.00% 66.0¢ orthocell limited

Ann: OCC Signs Striate Global License And Manufacturing Agreement, page-198

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 83 Posts.
    lightbulb Created with Sketch. 35
    https://hotcopper.com.au/data/attachments/4470/4470931-c7070d8104c59fd4822e240b3ffddc58.jpg

    kain calver previously posted this pricing

    there is no reason why OCC cannot continue to sell the product for theses prices which will have there profit margins in place.
    Even if they sell it slighty cheaper.
    the difference is only Bio horizons can buy it
    OCC set their price, sell it to Bio horizons. who put there mark up on it and sell it to those who want to save 7 months on the process of getting there teeth fixed

    as per the announcement

    - Orthocell will grant BioHorizons an exclusive licence of intellectual property (IP) relating to Striate+TM,a resorbable collagen membrane, manufactured by Orthocell, used for dental guided bone and tissue regeneration procedures

    - Orthocell will supply BioHorizons with Striate+TM products embodying the IP and grant exclusive distribution rights of those products globally

    -BioHorizons will market and distribute Striate+TM alongside its innovative and evidence-based dental implants and tissue regeneration products, to continue to improve the life of patients with missing teeth
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.